Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

SCYNEXIS PE Ratio 2013-2019 | SCYX

Current and historical p/e ratio for SCYNEXIS (SCYX) from 2013 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. SCYNEXIS PE ratio as of March 27, 2020 is 0.00.
  
SCYNEXIS PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-03-27 0.72 0.00
2019-12-31 0.91 $-0.77 0.00
2019-09-30 1.07 $-0.73 0.00
2019-06-30 1.31 $-0.57 0.00
2019-03-31 1.51 $-0.64 0.00
2018-12-31 0.48 $-0.30 0.00
2018-09-30 1.20 $-0.61 0.00
2018-06-30 1.64 $-0.93 0.00
2018-03-31 1.34 $-0.86 0.00
2017-12-31 2.32 $-0.99 0.00
2017-09-30 2.41 $-0.72 0.00
2017-06-30 1.79 $-0.89 0.00
2017-03-31 2.76 $-1.29 0.00
2016-12-31 3.19 $-1.56 0.00
2016-09-30 3.87 $-1.56 0.00
2016-06-30 2.17 $-1.68 0.00
2016-03-31 4.03 $-1.90 0.00
2015-12-31 6.21 $-2.13 0.00
2015-09-30 7.28 $-2.23 0.00
2015-06-30 8.79 $-2.08 0.00
2015-03-31 8.30 $-2.28 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.075B $0.000B
SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.999B 32.39
Takeda Pharmaceutical (TAK) Japan $47.260B 8.28
Astellas Pharma (ALPMY) Japan $27.822B 13.90
Eisai (ESALY) Japan $20.849B 38.84
Grifols, S.A (GRFS) Spain $13.421B 16.68
Merck (MKGAF) Germany $12.451B 16.33
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.539B 237.23
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.384B 30.38
Ionis Pharmaceuticals (IONS) United States $6.926B 20.99
Jazz Pharmaceuticals (JAZZ) Ireland $5.655B 6.90
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.299B 0.00
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.549B 0.00
IPSEN SA ADR (IPSEY) France $4.173B 0.00
United Therapeutics (UTHR) United States $4.038B 0.00
Hypermarcas (HYPMY) Brazil $3.970B 12.08
Evotec AG (EVTCY) Germany $3.485B 56.21
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 57.72
Nektar Therapeutics (NKTR) United States $3.109B 0.00
FibroGen (FGEN) United States $2.976B 0.00
PTC Therapeutics (PTCT) United States $2.720B 0.00
ChemoCentryx (CCXI) United States $2.460B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.375B 9.61
Xencor (XNCR) United States $1.725B 70.44
Sage Therapeutics (SAGE) United States $1.607B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.595B 19.39
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.578B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.467B 0.00
Karyopharm Therapeutics (KPTI) United States $1.392B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.364B 37.29
USANA Health Sciences (USNA) United States $1.344B 14.11
Corcept Therapeutics (CORT) United States $1.261B 14.10
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.084B 0.00
Zogenix (ZGNX) United States $1.074B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.032B 14.38
Esperion Therapeutics (ESPR) United States $1.029B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.991B 30.69
Akebia Therapeutics (AKBA) United States $0.977B 0.00
Endo (ENDP) Ireland $0.855B 1.58
Tilray (TLRY) Canada $0.822B 0.00
Radius Health (RDUS) United States $0.666B 0.00
Molecular Templates (MTEM) United States $0.658B 0.00
Aerie Pharmaceuticals (AERI) United States $0.627B 0.00
ImmunoGen (IMGN) United States $0.617B 0.00
Translate Bio (TBIO) United States $0.615B 0.00
Collegium Pharmaceutical (COLL) United States $0.583B 0.00
Portola Pharmaceuticals (PTLA) United States $0.551B 0.00
Indivior (INVVY) United States $0.509B 3.03
Corbus Pharmaceuticals Holdings (CRBP) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.402B 13.41
Ardelyx (ARDX) United States $0.395B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.390B 15.99
Innate Pharma SA (IPHYF) France $0.385B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.385B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.374B 0.00
Organogenesis Holdings (ORGO) United States $0.373B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.352B 0.00
TherapeuticsMD (TXMD) United States $0.350B 0.00
Flexion Therapeutics (FLXN) United States $0.337B 0.00
Trillium Therapeutics (TRIL) Canada $0.325B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Harpoon Therapeutics (HARP) United States $0.301B 0.00
DURECT (DRRX) United States $0.294B 0.00
Lannett Co Inc (LCI) United States $0.291B 4.69
Calithera Biosciences (CALA) United States $0.289B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.273B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.270B 0.00
Ocular Therapeutix (OCUL) United States $0.257B 0.00
CASI Pharmaceuticals (CASI) United States $0.222B 0.00
OptiNose (OPTN) United States $0.191B 0.00
Rafael Holdings (RFL) United States $0.189B 0.00
Recro Pharma (REPH) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 22.15
MEI Pharma (MEIP) United States $0.171B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.07
PROFOUND MEDICL (PROF) Canada $0.156B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.154B 0.00
KalVista Pharmaceuticals (KALV) United States $0.137B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.135B 0.00
Taiwan Liposome (TLC) Taiwan $0.128B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.106B 0.00
CannTrust Holdings (CTST) Canada $0.105B 0.00
Redhill Biopharma (RDHL) Israel $0.097B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
IMV INC (IMV) Canada $0.087B 0.00
Xeris Pharmaceuticals (XERS) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.078B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.075B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.073B 0.00
CV Sciences (CVSI) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.068B 0.00
Aquestive Therapeutics (AQST) United States $0.068B 0.00
Biomerica (BMRA) United States $0.065B 0.00
Otonomy (OTIC) United States $0.063B 0.00
Hemispherx BioPharma (AIM) United States $0.058B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.058B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.056B 17.62
Infinity Pharmaceuticals (INFI) United States $0.054B 0.00
PharmAthene (ALT) United States $0.050B 0.00
Aclaris Therapeutics (ACRS) United States $0.049B 0.00
PolarityTE (PTE) United States $0.048B 0.00
MediWound (MDWD) Israel $0.046B 0.00
Onconova Therapeutics (ONTX) United States $0.045B 0.00
Nivalis Therapeutics (ALPN) United States $0.045B 0.00
GTx (ONCT) United States $0.043B 0.00
Natural Alternatives (NAII) United States $0.042B 19.19
AgeX Therapeutics (AGE) United States $0.042B 0.00
Neos Therapeutics (NEOS) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.29
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
IsoRay (ISR) United States $0.039B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.026B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
India Globalization Capital (IGC) United States $0.025B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.024B 7.55
Bellicum Pharmaceuticals (BLCM) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
Novan (NOVN) United States $0.020B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Bio-Path Holdings (BPTH) United States $0.014B 0.00
ElectroCore (ECOR) United States $0.014B 0.00
Vical (BBI) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.012B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.005B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00